Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab.
Clemow DB. et al, (2025), J Patient Rep Outcomes, 9
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study.
Joustra VW. et al, (2025), Lancet Gastroenterol Hepatol
Which first? Surgery or biologic therapy for ileocolic Crohn's disease in the real world.
Witjes CDM. et al, (2025), Expert review of gastroenterology & hepatology, 19, 817 - 824
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis
Panaccione R. et al, (2025), Crohn's & Colitis 360, 7
Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trial.
Hameed M. et al, (2025), The British journal of radiology, 98, 527 - 534
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease.
Sakai NS. et al, (2025), Insights Imaging, 16
Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn's Disease Commencing Biological Therapy: The Motility Study.
Plumb AA. et al, (2025), Inflamm Bowel Dis
Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management.
Hill R. et al, (2025), Gastroenterol Hepatol (N Y), 21, 46 - 58
The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn's Disease.
Dubinsky M. et al, (2024), Adv Ther
Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study.
Griffiths BJ. et al, (2024), Clin Gastroenterol Hepatol
Gaps in acute upper GI bleed (AUGIB) endoscopy training: a UK trainees and trainers’ survey
Nigam GB. et al, (2024), Frontline Gastroenterology
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.
Thomas T. et al, (2024), Nat Immunol, 25, 2152 - 2165
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies.
Goodday SM. et al, (2024), J Med Internet Res, 26
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial.
de Cates AN. et al, (2024), Br J Psychiatry, 1 - 8
Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
Griffin H. et al, (2024), N Engl J Med, 391, 434 - 441
Mucosal Healing with Vedolizumab in Patients with Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial.
Jairath V. et al, (2024), Clin Gastroenterol Hepatol
Patient interpretations of patient-reported outcome measures to assess bowel urgency: qualitative interviews in ulcerative colitis.
Jairath V. et al, (2024), J Patient Rep Outcomes, 8